Raymond Capex To Revenue vs Ebit Per Revenue Analysis
RJF Stock | USD 169.28 0.82 0.48% |
Raymond James financial indicator trend analysis is much more than just breaking down Raymond James Financial prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Raymond James Financial is a good investment. Please check the relationship between Raymond James Capex To Revenue and its Ebit Per Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Raymond James Financial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Capex To Revenue vs Ebit Per Revenue
Capex To Revenue vs Ebit Per Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Raymond James Financial Capex To Revenue account and Ebit Per Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Raymond James' Capex To Revenue and Ebit Per Revenue is -0.17. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Ebit Per Revenue in the same time period over historical financial statements of Raymond James Financial, assuming nothing else is changed. The correlation between historical values of Raymond James' Capex To Revenue and Ebit Per Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Raymond James Financial are associated (or correlated) with its Ebit Per Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit Per Revenue has no effect on the direction of Capex To Revenue i.e., Raymond James' Capex To Revenue and Ebit Per Revenue go up and down completely randomly.
Correlation Coefficient | -0.17 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Ebit Per Revenue
Most indicators from Raymond James' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Raymond James Financial current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Raymond James Financial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. At this time, Raymond James' Enterprise Value Over EBITDA is most likely to slightly decrease in the upcoming years. The Raymond James' current Enterprise Value Multiple is estimated to increase to 4.90, while Tax Provision is projected to decrease to roughly 406.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 10.6B | 11.2B | 14.7B | 15.5B | Total Revenue | 10.9B | 11.5B | 14.9B | 15.7B |
Raymond James fundamental ratios Correlations
Click cells to compare fundamentals
Raymond James Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Raymond James fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 210.3M | 211.2M | 215.3M | 216.9M | 212.3M | 197.6M | |
Total Assets | 47.5B | 61.9B | 81.0B | 78.4B | 83.0B | 87.1B | |
Short Long Term Debt Total | 30.5B | 36.0B | 3.9B | 3.1B | 3.1B | 3.9B | |
Total Stockholder Equity | 7.1B | 8.2B | 9.5B | 10.2B | 11.7B | 12.3B | |
Property Plant And Equipment Net | 856M | 945M | 983M | 1.1B | 1.3B | 1.4B | |
Net Debt | (2.1B) | (4.3B) | (2.8B) | (6.2B) | (7.9B) | (7.5B) | |
Retained Earnings | 6.5B | 7.6B | 8.8B | 10.2B | 11.9B | 12.5B | |
Cash | 5.4B | 7.2B | 6.2B | 9.3B | 11.0B | 11.5B | |
Non Current Assets Total | 10.1B | 11.1B | 2.6B | 78.6B | 1.9B | 1.8B | |
Non Currrent Assets Other | (262M) | (305M) | (12.4B) | (12.6B) | (11.3B) | (10.8B) | |
Other Assets | 20.9B | 31.4B | 59.4B | (13.9B) | 59.1B | 62.1B | |
Cash And Short Term Investments | 13.0B | 15.5B | 16.1B | 9.3B | 19.3B | 20.2B | |
Net Receivables | 3.4B | 3.8B | 4.5B | 4.1B | 2.7B | 2.5B | |
Liabilities And Stockholders Equity | 47.5B | 61.9B | 81.0B | 78.4B | 83.0B | 87.1B | |
Non Current Liabilities Total | 3.3B | 2.9B | 11.4B | 66.3B | 3.1B | 5.8B | |
Other Stockholder Equity | (5.9B) | (7.0B) | 1.5B | 891M | 200M | 210M | |
Total Liab | 40.3B | 53.6B | 71.5B | 68.2B | 71.3B | 74.9B | |
Total Current Assets | 16.4B | 19.3B | 19.0B | 13.7B | 22.0B | 21.5B | |
Other Current Liab | (6.8B) | (14.0B) | (11.4B) | (10.4B) | (5.8B) | (5.5B) | |
Total Current Liabilities | 6.8B | 14.0B | 11.4B | 12.4B | 7.8B | 7.9B | |
Accounts Payable | 6.8B | 14.0B | 11.4B | 5.4B | 5.8B | 4.6B | |
Short Term Investments | 7.7B | 8.3B | 9.9B | 9.2B | 8.3B | 11.0B | |
Property Plant And Equipment Gross | 856M | 1.8B | 1.9B | 2.2B | 2.5B | 2.6B | |
Accumulated Other Comprehensive Income | 11M | (41M) | (982M) | (971M) | (502M) | (476.9M) | |
Short Term Debt | 27.2B | 32.9B | 583M | 456M | 524.4M | 498.2M | |
Other Liab | 27.7B | 33.4B | 51.9B | 54.7B | 62.9B | 66.1B | |
Long Term Debt | 3.3B | 3.1B | 3.3B | 3.1B | 3.6B | 3.8B | |
Good Will | 466M | 660M | 1.4B | 1.4B | 1.5B | 2.3B | |
Inventory | 14.2B | 23.6B | 19.1B | 16.4B | 18.9B | 19.9B | |
Treasury Stock | (447.3M) | (1.2B) | (1.4B) | (1.4B) | (1.3B) | (1.2B) | |
Intangible Assets | 134M | 222M | 509M | 470M | 435M | 456.8M | |
Property Plant Equipment | 535M | 945M | 983M | 1.1B | 1.3B | 1.4B | |
Current Deferred Revenue | (20.4B) | (18.9B) | 10.9B | 5.0B | 5.7B | 6.0B | |
Other Current Assets | (10.7B) | (14.2B) | (23.6B) | (20.7B) | 209M | 220M |
Currently Active Assets on Macroaxis
When determining whether Raymond James Financial is a strong investment it is important to analyze Raymond James' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Raymond James' future performance. For an informed investment choice regarding Raymond Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Raymond James Financial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Investment Banking & Brokerage space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Raymond James. If investors know Raymond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Raymond James listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.417 | Dividend Share 1.8 | Earnings Share 9.7 | Revenue Per Share 61.69 | Quarterly Revenue Growth 0.132 |
The market value of Raymond James Financial is measured differently than its book value, which is the value of Raymond that is recorded on the company's balance sheet. Investors also form their own opinion of Raymond James' value that differs from its market value or its book value, called intrinsic value, which is Raymond James' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Raymond James' market value can be influenced by many factors that don't directly affect Raymond James' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Raymond James' value and its price as these two are different measures arrived at by different means. Investors typically determine if Raymond James is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Raymond James' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.